SecBot SecBot
SECBOTREPLAY Home › Report › TVTX

TVTX · Fidelity stake 6.1%

Travere Therapeutics, Inc. · SC 13G/A filed Nov 5, 2026 at 13:27 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:27 ET

FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 6.1% passive stake in Travere Therapeutics as of September 30, 2026, up from 5.0% in the prior filing. The increase follows strong Q3 FILSPARI sales of $200.2M (up 120% YoY) reported on November 2, 2026. This is a routine passive stake update with no change in investment intent.

  • FMR LLC reported beneficial ownership of 5,707,883 shares of Travere Therapeutics common stock as of September 30, 2026
  • The stake represents 6.1% of shares outstanding
  • This is an amendment to a Schedule 13G, indicating passive investment intent
  • The prior FMR LLC filing (August 6, 2026) reported a 5.0% stake

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access